Clinical Trial Update: A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adjuvant transarterial chemoembolization (TACE) after liver resection for hepatocellular carcinoma has completed. The update discusse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED